RBC Inclusions
Inclusion | Composition | Seen in |
HowellâJolly bodies | ⢠DNA remnants | ⢠Post-splenectomy ⢠Megaloblastic ⢠Sickle cell disease (NOT THALASSEMIA) ⢠Dyshematopoiesis ⢠Hemolytic anemia |
Reticulocytes | ⢠Residual RNA (bluish network) | ⢠Hemolysis ⢠Blood loss ⢠Response to therapy |
Basophilic Stippling | ⢠Ribosomal RNA | ⢠Coarse â Lead poisoning ⢠Fine â Thalassemia, Megaloblastic Anemia ⢠Also seen in 5â Pyrimidine nucleotidase |
Heinz bodies | ⢠Hb denaturation ⢠Stained by Crystal Violet stain ⢠(Supravital stain) | ⢠G6PD |
Pappenheimer Bodies | ⢠Iron granules | ⢠Sideroblastic anemia ⢠Post-splenectomy |
Cabot Rings | ⢠Arginine-rich ⢠Mitotic spindle remnants ⢠Figure of eight/loop | ⢠Severe anemia ⢠Megaloblastic anemia ⢠Sideroblastic anemia |
Hemoglobin H inclusions | ⢠β4 tetramers ⢠(precipitated Hb H) | ⢠ι-thalassemia (Hb H disease) |
Siderotic Granules | ⢠Iron ⢠In Prussian blue stain | ⢠Sideroblastic states |
Target cells | ă
¤ | ⢠Thalassemia ⢠Iron deficiency anemia ⢠Liver disease ⢠Post-splenectomy ⢠Hemoglobin C disease |
Dohle bodies | ⢠ER remnant | ⢠Bacterial sepsis |
Perinuclear hof | ⢠Golgi apparatus | ⢠Plasma cells |





Hemoglobinopathies
Sickle Cell Anemia (SCA)



Mnemonic: Hafsa () Crew (Crew cut) autoyil () vannapo Sickle () eduth Fish cut (fish mouth) cheyth â Soda yum Meatum (2% sodium metabisulfate) kazhichapo â Drip ayi (Drepanocytes)
Genetic defect:
- Inheritance: Autosomal recessive.
- Most common Structural Hemoglobinopathy.
- A point mutation in the 6th codon of the β-globin gene in chromosome 11
- forming HbS.
- Non-conservative missense mutation
- Replacement of polar (glutamic acid) with a non-polar (valine)
- Sickle cells alias:Â
- Drepanoocytes.
- Property:Â
- Sticky, cause occlusion.
- Deoxygenated HbS polymerizes.
- Triggers:
- Low Oâ (e.g., high altitude, acidosis).
- High HbS concentration (e.g., dehydration).
- Results in sickling of RBCs â crescent-shaped RBCs â vaso-occlusion.
- Target cells, Hb crystals â seen in HbSC homozygotes.
Pathophysiology:
- HbS formed has different physiochemical properties.
- Microvascular obstruction leads to ischemia & tissue damage.
Sickle Cell Trait
- Heterozygotes have malaria resistance.
Clinical Finding:Â
- Anemia;
- Pallor, generalized weakness.
- Usually presents after 6 months of age.
- Most common cause of death - infections.
- MCC of osteomyelitis in Sickle cell disease is Salmonella.
- Normal : Staph Aureus
- Fishmouth vertebra
- "Crew cut" skull X-ray â marrow hyperplasia.
- Also seen in thalassemia.
- Newborns
- Asymptomatic at birth.
- Due to â HbF, â HbS.
- â risk of infection by encapsulated organisms.
- e.g., Salmonella osteomyelitis.
Ischemia
- CNS: Stroke.
- Retinopathy.
- Hand - Dactylitis.
- Priapism in males.
- Pulmonary
- Acute chest syndrome:
- Respiratory distress.
- New infiltrates on CXR.
- Commonest cause of death.
- Pulmonary artery hypertension.
- Renal
- Sickling in medulla â renal papillary necrosis.
- Causes hematuria (also in sickle cell trait).
- Hyposthenuria â inability to concentrate urine.
- Splenic infarct/sequestration crisis:
- Splenomegaly due to red pulp congestion.
- Auto splenectomy due to repeated splenic infarcts.
- Due to repeated infarctions.
- Leads to Howell-Jolly bodies.
Crisis in SCD
- Painful crises:
- Dactylitis â painful swelling of hands/feet.
- Aplastic Crisis
- Caused by Parvovirus B19.
- Leads to transient arrest of erythropoiesis.
- Vaso occlusive crisis:
- Painful Ischemia.
- Hemolytic crisis.
- Splenic sequestration.
- Acute chest syndrome.
Other Crises
- Priapism.
- Leg ulcer.
- Growth retardation.
- Retinopathy.
H shaped vertebra

- H-shaped Appearance or Lincoln Log Vertebrae.
- Seen in Sickle Cell Anemia.
- Depressed end plate, predominantly in the center.
- Lateral part is flat.
- In later stages: Fish mouth vertebra.
Tests:
Peripheral Smear:
- Sickle cells.
- Evidence of hemolysis, Sickle cells, Howel Jolly bodies

Sickling test:Â
- Adds 2% sodium metabisulfite or dithionate
- induces sickling of RBCs if HbS is present.
Hb Electrophoresis:

- Migration (Anode to Cathode):Â
- A FAT SANTA CLAUSE
- HbS is less mobile compared to regular Hb
- Negatively charged Polar Glutamate is replaced by non polar valine
- â Poorly attracted to anode
Investigation | Finding |
Hb Electrophoresis | â HbA, â HbF, â HbS |
Peripheral Smear | - Sickle cells - Howell-Jolly bodies (autosplenectomy) - Target cells, Hb crystals in HbS carrier |
- Hb Electrophoresis to detect HbS peak.

Spleen biopsy:
- Gamma Gandy bodies.
Gold Standard:Â
- HPLCÂ (High-Performance Liquid Chromatography).
Treatment:Â
- Maintain hydration.
- Avoid infections & immunization of the child.
- Infections
- Treat with appropriate antibiotics.
- Acute painful crisis: Analgesia with NSAIDs.
- Blood transfusion.
- Hydroxyurea
- ââ HbF levels and
- ââ the requirement for blood transfusions.
- Regular blood transfusion is the mainstay of the treatment.
- Hematopoietic stem cell transplant and gene therapy.
- Progestrone â sickling crisis
Newer drugs:
- Voxelotor to increase oxygen affinity and reduce HbS polymerization.
- L-glutamine to reduce vaso-occlusion.
- Crizanlizumab also ââ vaso-occlusion.
Â
Q. A 2-year-old boy is brought with episodes of icterus and pallor. On examination, Splenomegaly is positive and a family history of similar illness in the father is observed. PS is shown below. What is the diagnosis?
- Ans. Hereditary Spherocytosis (AD).

Q. A child with severe pallor presents with bleeding manifestations. On examination, no hepatosplenomegaly. Bm biopsy shows full of fat globules, What is the diagnosis
ANS
Aplastic anemia
Drug | Mechanism | Key Effects / Uses | Notes |
Hydroxyurea | â HbF Inhibits ribonucleotide reductase | - DOC (Drug of Choice) - Reduces vaso-occlusive crises - Improves Oâ carrying capacity | - Myelosuppressive - Approved for all ages - Used in CML, polycythemia Mnemonic: Hydro â mutram ozhikkuna fetus â HbF |
L-Glutamine | Reduces oxidative stress in sickle RBCs | Used in: ⣠Age >5 yrs ⣠Pain persists despite hydroxyurea ⣠Cannot tolerate hydroxyurea | Can be used with or without hydroxyurea |
Voxelotor | â HbS polymerization Stabilizes sickle Hb | - Reduces sickling | ă
¤ |
Crizanlizumab | P-selectin blocking monoclonal antibody | - Used for painful crises management | - Given IV monthly Mnemonic: Painful cry â (P selectin) Crizanlizumab in crisis |
Hydration | Supportive measure | - Helps reduce sickling | ă
¤ |
Aplastic Anemia
- Inherited/acquired condition +
- pancytopenia with hypo / acellular bone marrow.
- Clinical features:
- Pancytopenia:
- Anemia: Pallor, easy fatiguability.
- Thrombocytopenia: Bleeding manifestations.
- Leukopenia: Fever, recurrent infections.
- No lymphadenopathy.
- No hepatosplenomegaly.
Q. An otherwise well-child presented with generalized petechiae and gum bleeding. There is a history of viral URI 2 weeks back. What is the diagnosis?
ANS
- ITP (Idiopathic/Immune Thrombocytopenic Purpura).
Hemoglobin C Disease

- Genetic defect:
- Beta-globin gene, Glutamate â Lysine at beta-6 position.
- Peripheral Smear:
- Characteristic HbC crystals inside RBCs.
Thalassemia

- Genetic disorders:
- Decreased production of globin chains.
- Autosomal recessive.
- Chromosome 16 del â Îą Thalassemia
- Chromosome 11 splicing â β Thalassemia
- Osmotic Fragility:Â
- Low fragility (tough), graph shifts left.

Alpha Thalassemia:

Cause:
- Alpha gene deletion (Normal: 4 alpha genes).
Alpha gene deletion | Condition | Key Features |
1 gene AA/A- | Asymptomatic carrier | No symptoms |
2 genes AA/â | Alpha thal trait | - Can be Îąâş (cis) or Îąâ° (trans) - Mild anemia Mnemonic: 2 trait |
3 genes A-/â | HbH disease | - Formation of βâ tetramers (HbH) - Golf ball inclusions Mnemonic: He (HbH) is Playing Golf (Golf ball) at 3am in the morning (bcz gf left him) |
4 genes â/â | Hb Bart's disease | - Formation of Îłâ tetramers (Hb Bart's) - Causes hydrops fetalis- Intrauterine death Mnemonic: - Barr barr (bart) fetus - Gaya fetus (Îł) |
Beta Thalassemia:
- Cause: Beta globin gene mutation ("badlna").
Most common mutation (India):
- Splicing mutation
- IVS 1-5 GâC.
- Common Mutations in India:
- IVS 1-5 GâC.
- IVS 1-1 GâT.
- Codon 41/42.
- Frameshift occurs
- +8/9
- +41/42
Only possible deletion:Â
- 619 base pair deletion.
Beta Thalassemia Major (Koul's Anemia):


Transfusion dependent.
- Iron overload from repeated transfusions.
- Severe anemia (Hb 3-5 g).
- Palar, jaundice, splenomegaly.
Diagnosis Gold Standard:
- HPLC.
- HbF elevated (>90%).
Beta Thalassemia Major (Koul's Anemia):
- 'Hair on End' or 'Crew Cut appearance'.
- Lateral Xray skull: -Seen in hemolytic anaemias.
- e.g. sickle cell anemia, thalassemia.
- Hemolysis causes compensatory increase in hematopoiesis.

- Chipmunk faces/ Hemolytic Facies:
- Frontal prominence.
- Depressed bridge of the nose.
- Maxillary prominence.
- Severe anemia.
- Manifest later
- HbF in infants
- Transfusion requirement.
- Hemolytic jaundice.
- Splenomegaly.
- Short stature.
- Features of iron toxicity.
Peripheral Smear:
- Hemolytic anemia:
- Low Hb, low MCV, low MCH (thalassemia major).
- Microcytic-hypochromic anemia.
- Target cells/ Codocytes
- Howell jolly bodies.
- Poikilocytosis.
- Increased LDH.
- Increased unconjugated bilirubin.

Beta Thalassemia Minor:
- Mild/asymptomatic
- Hb > 8 g
- normal iron studies
- Microcytic hypochromic.
Differentiation from IDA:
- Mentzer Index
- Formula: (MCV / RBC count) x 100.
- Interpretation:
- <13: Thalassemia minor
- Mnemonic: Tha Lessemia â < 13
- >13: Iron Deficiency Anemia

- RDW:
N: 11.5 - 14.5 % | Conditions | Notes |
â RDW | ⢠B12 Deficiency ⢠IDA ⢠Hemolytic Anemia | ⢠Due to fluctuating raw material |
Normal RDW | ⢠Thalassemia Trait | ⢠Microcytic Hypochromic Anemia |
- Coombs test:
- Negative
Confirmation:
- Elevated HbA2 levels (>3.5%)Â by HPLC.
- Hb HPLC (High performance liquid chromatography) / Hb electrophoresis:
- Hb A (ι2 β2) decreased.
- Hb A2 (ι2 δ2) increased.
- Beta thalassemia trait:
- Hb A2 : 3.5%-7%.
- HbF (Îą2 Îł2) increased.


Definitive diagnosis:
- Globin gene mutation
- helps in prenatal diagnosis in the next pregnancy.
Osmolar fragility:


- (NESTROFT â Naked Eye Single Red Tube Cell Osmotic Fragility Test).
- Decreased
- Thalassemia cells (tough) in saline:
- Lines absent behind tube.
(Thal Assemia, Absent lines).
- Normal cells (break):
- Lines visible.


Treatment of Thalassemia:
- Regular Blood Transfusions (PRBC):
- To maintain pretransfusion Hb level between 9-10.5 g/dL.
- The only curative treatment:
- Hematopoietic stem cell transplantation (HSCT).
- Iron Chelation Therapy:
- Desferrioxamine/Deferoxamine
- Injectable
- DOC for acute Iron poisoning
- When Iron level > 500 Microgram/dl
- Monitor for hypotension, pulmonary toxicity.
- Oxygen â acute â IV â but BP falls and Lung injury
- Deferiprone
- Oral
- Used for chronic Iron overload
- Agranulocytosis
- needs weekly blood monitoring
- Best for cardiac iron;
- Chronic Ferry Pirates (Feripirone) â oral
- Prone (Deferiprone) Close (Clozapine) Car (Carbamazepine) â Agranulocytosis
Haemophilia A
- Basic defect: Deficiency of factor VIII.
- Inheritance:
- X-linked recessive
- Family h/o maternal uncles being affected.
Classification:
- Mild (factor VIII >5%).
- Moderate (factor VIII 1-5%).
- Severe (factor VIII <1% factor level).
Clinical features:
- H/o joint swelling following trauma (Ankle>knee joint).
- Deep bleeding.
Investigation:
- Prolonged aPTT
- but normal PT, BT, and platelet counts.
- Low factor VIII levels.
Treatment:
- Factor VIII replacement is TOC
- If not available âuse fresh frozen plasma (FFP).
- Cryoprecipitate.
- Avoid contact sports.
- Precautions during immunization
- Compress the site of injection to prevent the formation of a hematoma.
Cancer-Associated Thrombosis (CAT)
Management
Low Molecular-Weight Heparin vs. Oral Anticoagulants:
- CLOT trial
- All recent guidelines now favor LMWH for cancer-associated thrombosis
LMWH
- Preferred due to bioavailability,
- Lack of need for anticoagulant monitoring
- Long t1/2
- Tinzaparine - used for maintainence
Unfractionated Heparin (UFH):
- Can be used in patients with renal failure

